ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 156 filers reported holding ACORDA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -20.0% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -28.6% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | +20.0% | 250 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -99.4% | 250 | -99.3% | 0.00% | -100.0% |
| Q3 2017 | $872,000 | +21.8% | 36,866 | +1.4% | 0.03% | +14.3% |
| Q2 2017 | $716,000 | -3.8% | 36,346 | +2.5% | 0.03% | -6.7% |
| Q1 2017 | $744,000 | +18.5% | 35,451 | +6.1% | 0.03% | +11.1% |
| Q4 2016 | $628,000 | -9.9% | 33,410 | -0.0% | 0.03% | -10.0% |
| Q3 2016 | $697,000 | -18.5% | 33,414 | -0.3% | 0.03% | -21.1% |
| Q2 2016 | $855,000 | -2.4% | 33,511 | +1.2% | 0.04% | -2.6% |
| Q1 2016 | $876,000 | -38.1% | 33,107 | 0.0% | 0.04% | -39.1% |
| Q4 2015 | $1,416,000 | +63.1% | 33,107 | +1.1% | 0.06% | +52.4% |
| Q3 2015 | $868,000 | -20.5% | 32,761 | 0.0% | 0.04% | -12.5% |
| Q2 2015 | $1,092,000 | +0.2% | 32,761 | 0.0% | 0.05% | -4.0% |
| Q1 2015 | $1,090,000 | -18.6% | 32,761 | 0.0% | 0.05% | -21.9% |
| Q4 2014 | $1,339,000 | +20.6% | 32,761 | 0.0% | 0.06% | +18.5% |
| Q3 2014 | $1,110,000 | +0.5% | 32,761 | 0.0% | 0.05% | 0.0% |
| Q2 2014 | $1,104,000 | -11.1% | 32,761 | 0.0% | 0.05% | -15.6% |
| Q1 2014 | $1,242,000 | +29.8% | 32,761 | 0.0% | 0.06% | +30.6% |
| Q4 2013 | $957,000 | -14.6% | 32,761 | 0.0% | 0.05% | -19.7% |
| Q3 2013 | $1,120,000 | -7.0% | 32,761 | -10.3% | 0.06% | -9.0% |
| Q2 2013 | $1,204,000 | – | 36,522 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|